CBDX.US Curative Biosciences Inc
- Market cap
- USD 3.16K
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Mar 2018.
Is CBDX.US undervalued?
Graham numberThe Graham number of Curative Biosciences Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Curative Biosciences Inc fundamental analysis
No fundamental analysis for Curative Biosciences Inc yet.
Curative Biosciences Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Curative Biosciences Inc
Curative Biosciences, Inc. focuses on developing and commercializing therapeutics using hemp-derived Cannabidiol. It intends to manufacture and market natural health products and operate in the medical cannabis industry. The company was formerly known as Amaize Beverage Corporation and changed its name to Curative Biosciences, Inc. in August 2017. Curative Biosciences, Inc. was founded in 2009 and is based in Miami, Florida.
Full company profileCurative Biosciences Inc financial statements
2018 annualized: Fiscal year 2018 is not finished. Income statement and cash flow are annualized from 3 quarters up to Mar 31, 2018, the balance sheet is the latest quarter. Figures change when the annual report is published.
Curative Biosciences Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2014 | 2015 | 2016 | 2017 | 2018 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | -53.2K | 0.00 | -2.85K | -2.85K | 0.00 |
| Operating Income | -469K | -1.71M | -1.64M | -53.2K | -667K |
| EBITDA | - | - | -1.65M | -50.3K | - |
| Net Income | -30.0M | -3.37M | -1.66M | -53.2K | -667K |
| EPS | - | - | -0.12 | 0.00 | -0.03 |
| Balance Sheet | |||||
| Total Assets | 15.7K | 9.96K | 5.11K | 2.27K | 13.9K |
| Total Liabilities | 381K | 706K | 620K | 633K | 720K |
| Shareholders' Equity | -366K | -696K | -615K | -631K | -706K |
| Cash & Short-term Investments | 1.82K | 2.00K | 0.00 | 0.00 | 982.00 |
| Total Debt | - | - | 50.0K | 62.8K | - |
| Cash Flow | |||||
| Operating Cash Flow | -144K | -65.4K | -29.0K | -12.8K | -107K |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | - | - | -29.0K | -12.8K | - |
| Ratios | |||||
| ROA | -191,671.0% | -33,814.3% | -32,413.2% | -2,348.6% | -4,808.1% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROA
- Return on assets: net income divided by total assets.
Curative Biosciences Inc dividends
Curative Biosciences Inc has not paid dividends in the last 4 fiscal years.
Last stock split: 1:100 on Oct 28, 2013.
Who owns Curative Biosciences Inc
Ownership data of Curative Biosciences Inc is not available yet.
Curative Biosciences Inc company profile
- Company name
- Curative Biosciences Inc
- Ticker
- CBDX.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Fiscal year end
- June
- Address
- 801 Brickell Avenue, Miami, FL, United States, 33131
- Website
- curativebio.com
About Curative Biosciences Inc
Curative Biosciences, Inc. focuses on developing and commercializing therapeutics using hemp-derived Cannabidiol. It intends to manufacture and market natural health products and operate in the medical cannabis industry. The company was formerly known as Amaize Beverage Corporation and changed its name to Curative Biosciences, Inc. in August 2017. Curative Biosciences, Inc. was founded in 2009 and is based in Miami, Florida.
Curative Biosciences Inc management
1- Ms. Katherine T. Alverson WestExecutive VP & Secretary · born 1970